| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |